Inventor · disambiguated record
Wilhelm Bone
Also filed as: BONE WILHELM
20 granted patents·9 pending applications·63 citations·filing 2010–2020
92Inventor score
Top patents by PatentIndex Score
29 records- 0196US9549932B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2016·Granted Jan 24, 2017·26 cites·30 claims
- 0289US9993484B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2015·Granted Jun 12, 2018·4 cites·9 claims
- 0386US10155004B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesBAYER IP GMBH·Filed 2017·Granted Dec 18, 2018·4 cites·3 claims
- 0485US11529356B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 0585US10772893B22-(morpholin-4-yl)-1,7-naphthyridinesBayer Pharma AG·Filed 2018·Granted Sep 15, 2020·2 cites·12 claims
- 0685US8278469B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesSCHWEDE WOLFGANG·Filed 2011·Granted Oct 2, 2012·7 cites·2 claims
- 0780US9717739B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesBAYER IP GMBH·Filed 2015·Granted Aug 1, 2017·2 cites·14 claims
- 0877US9682974B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·4 cites·8 claims
- 0975US9745285B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·3 cites·5 claims
- 1074US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 1174US9765058B2Substituted benzylpyrazolesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·3 cites·14 claims
- 1274US9085603B2Progesterone receptor antagonistsSCHWEDE WOLFGANG·Filed 2011·Granted Jul 21, 2015·3 cites·15 claims
- 1370US9109004B2Progesterone receptor antagonistsSCHWEDE WOLFGANG·Filed 2011·Granted Aug 18, 2015·2 cites·10 claims
- 1466US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 1551US2016046610A13-heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1650US2012149670A117-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseasesSCHWEDE WOLFGANG·Filed 2010·Application pending·0 cites
- 1744US2016145267A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1844US2016168130A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1942US2016151370A1Substituted BenzylpyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2040US10894784B2Heteroarylbenzimidazole compoundsBayer Pharma AG·Filed 2016·Granted Jan 19, 2021·0 cites·15 claims
- 2140US2014357655A1Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonistsBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 2238US9206219B217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseasesKLAR ULRICH·Filed 2010·Granted Dec 8, 2015·0 cites·12 claims
- 2338US9096640B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseasesKLAR ULRICH·Filed 2010·Granted Aug 4, 2015·0 cites·12 claims
- 2437US9156877B217-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseasesKLAR ULRICH·Filed 2010·Granted Oct 13, 2015·0 cites·10 claims
- 2537US9102701B217-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-ethynylphenyl derivatives, methods for the production thereof and use thereof for treating diseasesKLAR ULRICH·Filed 2010·Granted Aug 11, 2015·0 cites·10 claims
- 2635US2017275269A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2735US2017275270A1Benzyl substituted indazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2835US2017305882A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2933US10428044B23-amino-1,5,6,7-tetrahydro-4H-indol-4-onesBayer Pharma AG·Filed 2015·Granted Oct 1, 2019·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Wilhelm Bone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →